War in the Body The evolutionary arms race between HIV and the human immune system and the implications for vaccines /

Por Wick, W. David, Yang, Otto O
Publicado em 2013

Biologically-Directed Modeling Reflects Cytolytic Clearance of SIV-Infected Cells In Vivo in Macaques

Por Wick, W. David, Yang, Otto O.
Publicado em 2012

WHITE VARIANTS DERIVED FROM STAPHYLOCOCCUS AUREUS: COMPARISONS WITH PARENT STRAINS

Por Boniece, W. S., Wick, W. E., Holmes, D. H.
Publicado em 1957

P31-S Identification of Protein Biomarkers Associated with Hypoxia in Human Malignant Glioma Cell Lines Using Proteomics Technologies

Por Kempf, T., Rahn, S., Warnken, U., Schnoelzer, M., Wick, W.
Publicado em 2007

Cephaloglycin and Its Biologically Active Metabolite Desacetylcephaloglycin

Por Wick, W. E., Wright, W. E., Kuder, H. V.
Publicado em 1971

On Modeling HIV and T Cells In Vivo: Assessing Causal Estimators in Vaccine Trials

Por Wick, W. David, Gilbert, Peter B, Self, Steven G
Publicado em 2006

Predicting the Impact of Blocking Human Immunodeficiency Virus Type 1 Nef In Vivo

Por Wick, W. David, Gilbert, Peter B., Yang, Otto O.
Publicado em 2009

P04.69 Differential microglia - glioma cell interaction during tumor progression

Por Grosch, J, Osswald, M, Berghoff, A S, Wick, W, Winkler, F
Publicado no Neuro Oncol (2018)

IN VITRO AND IN VIVO LABORATORY EVALUATION OF CEPHALOTHIN, A NEW BROAD SPECTRUM ANTIBIOTIC

Por Boniece, W. S., Wick, W. E., Holmes, D. H., Redman, C. E.
Publicado em 1962

Compound 64716, a New Synthetic Antibacterial Agent

Por Wick, W. E., Preston, D. A., White, W. A., Gordee, R. S.
Publicado em 1973

How Many Human Immunodeficiency Virus Type 1-Infected Target Cells Can a Cytotoxic T-Lymphocyte Kill?

Por Wick, W. David, Yang, Otto O., Corey, Lawrence, Self, Steven G.
Publicado em 2005

P01.140 An H3.3K27M long peptide vaccine induces expansion of specific CD4 and CD8 T cell clones in a patient with progressive H3.3K27M-mutant midline glioma

Por Sahm, K, Mildenberger, I, Bunse, L, Green, E, Wick, W, Platten, M
Publicado no Neuro Oncol (2018)

New Synthetic Antibacterial Compound, 1-(2-Hydroxyethyl)-3-Nitro-4-Pyrazolecarboxamide

Por Wick, W. E., Preston, D. A., Terando, N. H., Welles, J. S., Gordee, R. S.
Publicado em 1973

OS1.6 Tumor Microtubes contribute to resistance against surgical lesions, and chemotherapy in malignant glioma

Por Weil, S., Osswald, M., Solecki, G., Blaes, J., Gömmel, M., Wick, W., Winkler, F.
Publicado no Neuro Oncol (2016)

OS3.5 Dynamic insights into the cellular heterogeneity of malignant gliomas

Por Xie, R, Kessler, T, Grosch, J, Huang, L, Solecki, G, Wick, W, Winkler, F
Publicado no Neuro Oncol (2018)

P02.08 Visualizing tumor cell - lymphocyte interactions in the brain metastatic cascade using in vivo two photon microscopy

Por Piechutta, M, Berghoff, A S, Karreman, M A, Gunkel, K, Wick, W, Winkler, F
Publicado no Neuro Oncol (2018)

Posterior Circulation Acute Stroke Prognosis Early Computed Tomography Score Using Hypointense Vessels on Susceptibility Weighted Imaging Independently Predicts Outcome in Patients...

Por Mundiyanapurath, S., Möhlenbruch, M., Ringleb, P. A., Bösel, J., Wick, W., Bendszus, M., Radbruch, A.
Publicado no PLoS One (2015)

P08.64 A NF-κB in vivo reporter system allows molecular insights into glioma progression and therapy response

Por Xie, R., Ratliff, M., Solecki, G., Karimian, K., Hänggi, D., Wick, W., Winkler, F.
Publicado no Neuro Oncol (2017)

P02.13 Before requiring a cure: towards preventing the outgrowth of brain metastases

Por Karreman, M A, Berghoff, A S, Gunkel, K, Piechutta, M, Feinauer, M, Wick, W, Winkler, F
Publicado no Neuro Oncol (2018)

OS07.1 Molecular differences in IDH wild type glioblastoma according to MGMT promoter methylation status

Por Kessler, T., Sahm, F., Sadik, A., Hertenstein, A., Bendszus, M., von Deimling, A., Platten, M., Wick, W.
Publicado no Neuro Oncol (2017)